These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36470050)

  • 21. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.
    Poms AD; Turner M; Farber HW; Meltzer LA; McGoon MD
    Chest; 2013 Jul; 144(1):169-176. PubMed ID: 23348820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The end-of-life experience for a cohort of patients with pulmonary arterial hypertension.
    Grinnan DC; Swetz KM; Pinson J; Fairman P; Lyckholm LJ; Smith T
    J Palliat Med; 2012 Oct; 15(10):1065-70. PubMed ID: 22845004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
    Chung L; Domsic RT; Lingala B; Alkassab F; Bolster M; Csuka ME; Derk C; Fischer A; Frech T; Furst DE; Gomberg-Maitland M; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TA; Molitor JA; Preston IR; Schiopu E; Shapiro L; Silver R; Simms R; Varga J; Gordon JK; Steen VD
    Arthritis Care Res (Hoboken); 2014 Mar; 66(3):489-95. PubMed ID: 23983198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative Care Perspectives of Patients with Pulmonary Arterial Hypertension.
    Brown CE; Steiner JM; Modes M; Lynch Y; Leary PJ; Curtis JR; Engelberg RA
    Ann Am Thorac Soc; 2023 Feb; 20(2):331-334. PubMed ID: 36416739
    [No Abstract]   [Full Text] [Related]  

  • 25. Lower socioeconomic status is associated with worse outcomes in pulmonary arterial hypertension.
    Wu WH; Yang L; Peng FH; Yao J; Zou LL; Liu D; Jiang X; Li J; Gao L; Qu JM; Kawut SM; Jing ZC
    Am J Respir Crit Care Med; 2013 Feb; 187(3):303-10. PubMed ID: 23220911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Hay BR; Pugh ME; Robbins IM; Hemnes AR
    Chest; 2016 Mar; 149(3):660-6. PubMed ID: 26378379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
    Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
    Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
    Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension.
    Boucly A; Savale L; Jaïs X; Bauer F; Bergot E; Bertoletti L; Beurnier A; Bourdin A; Bouvaist H; Bulifon S; Chabanne C; Chaouat A; Cottin V; Dauphin C; Degano B; De Groote P; Favrolt N; Feng Y; Horeau-Langlard D; Jevnikar M; Jutant EM; Liang Z; Magro P; Mauran P; Moceri P; Mornex JF; Palat S; Parent F; Picard F; Pichon J; Poubeau P; Prévot G; Renard S; Reynaud-Gaubert M; Riou M; Roblot P; Sanchez O; Seferian A; Tromeur C; Weatherald J; Simonneau G; Montani D; Humbert M; Sitbon O
    Am J Respir Crit Care Med; 2021 Oct; 204(7):842-854. PubMed ID: 34185620
    [No Abstract]   [Full Text] [Related]  

  • 32. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
    Salvador ML; Rodríguez-Padial L; Soto Abánades C; Cruz Utrilla A; Barberá Mir JA; López-Meseguer M; Segovia Cubero J; Samper GJ; Blanco Vich I; Escribano-Subías P; ;
    J Intern Med; 2022 Jul; 292(1):116-126. PubMed ID: 35184348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL.
    Farber HW; Badesch DB; Benza RL; Elliott CG; Frantz RP; McGoon MD; Selej M; Zhao C; Frost AE
    J Heart Lung Transplant; 2018 Aug; 37(8):948-955. PubMed ID: 29653800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
    Bercow AS; Nitecki R; Haber H; Gockley AA; Hinchcliff E; James K; Melamed A; Diver E; Kamdar MM; Feldman S; Growdon WB
    Int J Gynecol Cancer; 2021 Jan; 31(1):66-72. PubMed ID: 33046575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of pulmonary arterial hypertension.
    Jiang X; Jing ZC
    Curr Hypertens Rep; 2013 Dec; 15(6):638-49. PubMed ID: 24114080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience.
    Kaymaz C; Tanyeri S; Tokgöz HC; Akbal ÖY; Karagöz A; Keskin B; Kültürsay B; Hakgör A; Külahçıoğlu Ş; Bayram Z; Efe SÇ; Tanboğa İH; Doğan C; Akbulut M; Özdemir N
    Anatol J Cardiol; 2022 Oct; 26(10):778-787. PubMed ID: 36196862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.
    Matura LA; McDonough A; Carroll DL
    Eur J Cardiovasc Nurs; 2012 Mar; 11(1):51-61. PubMed ID: 22357779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry.
    Lazaro Salvador M; Quezada Loaiza CA; Rodríguez Padial L; Barberá JA; López-Meseguer M; López-Reyes R; Sala-Llinas E; Alcolea S; Blanco I; Escribano-Subías P;
    Intern Med J; 2021 Mar; 51(3):355-365. PubMed ID: 31943676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.